Search clinical trials for: Insulin glargine, 300 U/ml
Total 1015 results
-
SanofiTerminatedType 2 Diabetes Mellitus | Renal ImpairmentUnited States, Czechia, Hungary, Poland, Serbia
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Puerto Rico
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada
-
SanofiCompletedType 1 Diabetes MellitusFrance, Czechia, Chile, Israel, Spain, Hungary, Mexico, Serbia, Japan, Canada, Brazil, Sweden, Denmark, Argentina, United States, Bulgaria, Germany, Italy, Latvia, North Macedonia, Poland, Romania, Russian Federation, United Kingdom
-
Mira ZuidgeestSanofi; Innovative Medicines Initiative; IMI Trials@Home consortiumRecruitingDiabetes Mellitus, Type 2United Kingdom, Denmark, Germany
-
SanofiCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Israel, Czechia, Greece, Italy, United States, Bulgaria, Croatia, Denmark, France, Hungary, Romania, Serbia, Slovakia, Sweden, Switzerland, United Kingdom
-
SanofiCompletedType 1 Diabetes MellitusTurkey, Netherlands, Brazil, United States, Germany, Hungary, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Canada, Hungary, Germany, Turkey, Greece
-
prof dr Pieter GillardUniversity Hospital, Antwerp; Onze Lieve Vrouw HospitalCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1Germany
-
Changhua Christian HospitalRecruitingDiabetic Ketoacidosis | Hyperglycaemic Crisis in Diabetes Mellitus | Hyperglycaemic Hyperosmolar Nonketotic SyndromeTaiwan
-
Vanderbilt University Medical CenterSanofiCompleted
-
SanofiTerminatedType 1 Diabetes MellitusUnited States, Canada
-
University Hospital TuebingenTerminatedDiabetes Mellitus, Type 2Germany
-
Stanford UniversityUniversity of Colorado, Denver; BiodelWithdrawnDiabetes MellitusUnited States
-
Indonesia UniversityUnknownDiabetes MellitusIndonesia
-
GeropharmCompletedDiabetes Mellitus | Diabetes Mellitus, Type 1Russian Federation
-
Profil Institut für Stoffwechselforschung GmbHEmisphere Technologies, Inc.Completed
-
University of MinnesotaEli Lilly and CompanyCompletedInsulin Resistance | Type 2 Diabetes | High Insulin RequirementsUnited States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, United Kingdom, France, Netherlands, Finland, Germany, Sweden
-
Elaine ChowSanofiCompleted
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesGermany
-
SanofiTerminated
-
Shenzhen Second People's HospitalUnknown
-
SanofiCompletedType 2 Diabetes MellitusArgentina, Colombia, Egypt, Hong Kong, India, Indonesia, Lebanon, Malaysia, Peru, Philippines, Saudi Arabia, South Africa, Thailand, Turkey
-
Eli Lilly and CompanyCompleted
-
Novo Nordisk A/SCompletedComparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
AstraZenecaJuvenile Diabetes Research FoundationCompletedType 1 Diabetes MellitusUnited States
-
GE HealthcareQuintiles, Inc.; Physician Reference LaboratoryCompleted
-
Diasome PharmaceuticalsIntegriumCompletedDiabetes Mellitus, Type 1United States
-
SanofiTerminated
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTurkey
-
King Faisal Specialist Hospital & Research CenterCompletedDiabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral NutritionSaudi Arabia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Biocon LimitedProfil Institut für Stoffwechselforschung GmbHCompleted
-
Dance Biopharm Inc.Profil Institut für Stoffwechselforschung GmbHCompletedType 2 Diabetes MellitusGermany
-
SanofiCompleted
-
Aarhus University HospitalCompletedType 2 Diabetes MellitusDenmark
-
Diasome PharmaceuticalsIntegriumCompletedType1 Diabetes MellitusUnited States
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
SanofiCompletedDiabetes Mellitus Type 2Germany
-
University of AarhusCompletedDiabetes Mellitus, Type 1Denmark
-
IRCCS San RaffaeleTerminatedType 2 Diabetes Mellitus | Peripheral Vascular DiseaseItaly
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Johns Hopkins UniversityTerminatedHypoglycemia | Type 1 DiabetesUnited States